James Bullard said he dissented on this week's Fed decision to lower rates by a quarter percentage point because he didn't think the cut was big enough.The Fedread more
More than 400 Chinese products will be temporarily exempted from tariffs that President Donald Trump's administration imposed last year.China Economyread more
"I feel like I've contributed all I can to this primary election," he told MSNBC's "Morning Joe." "And it's clearly not my time. So I'm going to end my presidential campaign."2020 Electionsread more
Apple will get a taste of whether upgraded features on the new iPhone 11 are enough to lure shoppers to retail stores around the world as the new smartphones officially hit...Technologyread more
The complaint made by an unnamed intelligence official about the president centers on Ukraine, the Washington post reported.Politicsread more
Apple CEO Tim Cook greeted iPhone 11 customers at the reopening of the Fifth Avenue Apple store on Friday. CNBC also took a tour inside. Here's a look.Technologyread more
The Pentagon on Thursday said the recent attack on Saudi Arabian oil facilities were "sophisticated" and represented a "dramatic escalation" in tensions within the region.Defenseread more
U.S. stock futures are modestly higher, with the S&P 500 just a little more than 20 points away from July's all-time high ahead of Friday's open on Wall Street.Marketsread more
Bank of America says Amazon's plans to build its own fleet of carbon-neutral delivery trucks bode well for its bottom line.Investingread more
The show comes as social media platforms and legacy media companies alike have launched a flurry of original content alongside new streaming platforms like Apple TV+ and...Technologyread more
Pivotal Research Group began coverage of Roku with a sell rating on FridayInvestingread more
Shares of Johnson & Johnson rose in early trading Tuesday after an Oklahoma judge ordered to pay a far smaller fine than expected as a result of its involvement in the state's opioid crisis.
On Monday, the company was ordered to pay Oklahoma $572 million — significantly less than the $17 billion in penalties sought by the state. This was the first U.S. case attempting to hold a drug-maker accountable for fueling the opioid epidemic.
Shares of Johnson & Johnson rose more than 1.8% in early trading Tuesday, implying that the company could grow by more than $6 billion in market cap. Drugmaker Teva Pharmaceutical, Endo International and Mallinckrodt all rallied after the decision Monday. But the companies were trading lower after the opening bell Tuesday.
Teva Pharmaceutical and Purdue Pharma, the privately held maker of OxyContin that taken the brunt of the public's blame for the drug crisis, settled with the state before the trial began. Neither company admitted to any wrongdoing. J&J was the only defendant left in the seven-week trial.
In the landmark ruling Monday, judge Thad Balkman called the drug crisis an "imminent danger and menace" and said Johnson & Johnson and its pharmaceutical subsidiary Janssen "caused an opioid crisis that's evidenced by increased rates of addiction, overdose deaths and neonatal abstinence syndrome."
In an emailed statement to CNBC, Johnson & Johnson said it plans to appeal the case.
"Janssen did not cause the opioid crisis in Oklahoma, and neither the facts nor the law support this outcome," Johnson & Johnson general counsel Michael Ullmann said in a statement. "We recognize the opioid crisis is a tremendously complex public health issue and we have deep sympathy for everyone affected. We are working with partners to find ways to help those in need."
— CNBC's Berkeley Lovelace contributed reporting.